Posted by Michael Wonder on 18 Apr 2022
FDA’s breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies
18 April 2022 - Five years ago, the FDA launched a new program with the best of intentions: to speed the development and review of cutting-edge and potentially life-saving medical devices, all in the name of getting them to patients faster.
